top of page

Women - reduce your Cardio Vascular Risk by 20% with Semaglutide [Lancet]

A research article was published last week - and as it was brand new and relevant to many of our patients, I thought it’d be good to summarize it and share.


From the Lancet, a research paper was published that has unlocked incredible news for anyone thinking about starting semaglutide, or already on it! 


Semaglutide isn’t just a powerful tool for weight loss—it’s now proven to help your heart as well! Even if you don’t have diabetes, this medication greatly lowers your risk of serious cardiovascular events, like heart attacks and strokes. In the study, people who were overweight or obese with existing heart issues benefited from a 20% reduction in major heart problems compared to those not on treatment.


This isn’t just about the scale—semaglutide helps protect your heart in ways that go beyond weight loss.


For women especially, who may not always recognize their own cardiovascular risk, these findings are a game changer. Heart disease can fly under the radar for many females, but taking positive steps like starting semaglutide means you’re actively reducing your chance of dangerous heart issues down the road. It’s exciting to see science back up what we’re seeing with our patients every day: better health outcomes, peace of mind, and real protection for your future.


If you’re considering semaglutide or already on it, you can feel confident that you’re making a smart, preventive choice—not just for your weight, but for your heart health too. 


Interested in learning more or ready to start your semaglutide journey? Our experienced team at Pacific Northwest Medical Group is here to help you take charge and thrive!


Daryl and Jennifer Welsh


Pacific Northwest Medical Group

6622 112th ST E, Puyallup WA 98373

253-340-2270


ree

 
 
bottom of page